Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Humanized Anti-CεmX Antibody (h4B12) on IgE Production in the PBMC Isolated From Atopic Dermatitis Patients

NCT01995747 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01995747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01995747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Humanized Anti-CεmX Antibody (h4B12) on IgE Production in the PBMC Isolated From Atopic Dermatitis Patients
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
August 31, 2012
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis